Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000498011 | SCV000590686 | uncertain significance | not provided | 2017-06-20 | criteria provided, single submitter | clinical testing | The T478I variant in the KAT6A gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The T478I variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The T478I variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Threonine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret T478I as a variant of uncertain significance. |
Yale Center for Mendelian Genomics, |
RCV001849388 | SCV002106551 | association | Vein of Galen aneurysmal malformation | 2018-12-18 | no assertion criteria provided | literature only |